A recent study in Parkinson’s mouse models, a molecule in the brain called ophthalmic acid, is seen to improve movement for over 20 hours – far longer than the effects of the current treatment, L-dopa.

Ophthalmic acid acts like a neurotransmitter to regulate motor function, similar to dopamine. The findings of the study challenges the long-held belief that dopamine is the only key player in motor control and opens possibilities for ophthalmic acid as a potential treatment for motor disorders.

More information on the key facts on ophthalmic acids and the details of the research study can be found in an article on Neuroscience here.